BlossomHill Therapeutics, Inc. (BLSM)
NASDAQ: BLSM · Real-Time Price · USD
13.50
+1.15 (9.31%)
At close: Nov 6, 2026, 4:00 PM EST
13.48
-0.02 (-0.15%)
After-hours: Nov 6, 2026, 7:30 PM EST
BlossomHill Therapeutics Market Cap
BlossomHill Therapeutics has a market cap or net worth of $429.1 million as of November 6, 2026. It is the 15,313th most valuable company in the world and the 2,819th biggest in the United States.
Market Cap
429.10M
Enterprise Value
357.09M
1-Year Change
n/a
Global Rank
Country Rank
#2,819 United States
Category
ChartMarket Cap Chart
Since the IPO on August 7, 2026, BlossomHill Therapeutics's market cap has decreased from $465.30M to $429.10M, a decrease of -7.78%. That is a compound annual growth rate of -27.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 429.10M | 9.31% |
| Nov 5, 2026 | 392.54M | -0.24% |
| Nov 4, 2026 | 393.50M | -0.24% |
| Nov 3, 2026 | 394.45M | -0.08% |
| Nov 2, 2026 | 394.77M | -9.67% |
| Oct 30, 2026 | 437.04M | -9.60% |
| Oct 29, 2026 | 483.45M | -7.59% |
| Oct 28, 2026 | 523.18M | 4.47% |
| Oct 27, 2026 | 500.77M | -3.87% |
| Oct 26, 2026 | 520.95M | 12.03% |
| Oct 23, 2026 | 465.01M | -7.46% |
| Oct 22, 2026 | 502.52M | 1.35% |
| Oct 21, 2026 | 495.84M | 8.33% |
| Oct 20, 2026 | 457.70M | 1.69% |
| Oct 19, 2026 | 450.07M | 1.58% |
| Oct 16, 2026 | 443.08M | -6.94% |
| Oct 15, 2026 | 476.14M | -1.83% |
| Oct 14, 2026 | 485.04M | -1.42% |
| Oct 13, 2026 | 492.03M | -10.36% |
| Oct 12, 2026 | 548.93M | -1.20% |
| Oct 9, 2026 | 555.60M | 3.55% |
| Oct 8, 2026 | 536.53M | 1.63% |
| Oct 7, 2026 | 527.95M | -3.93% |
| Oct 6, 2026 | 549.56M | -13.29% |
| Oct 5, 2026 | 633.79M | 1.27% |
| Oct 2, 2026 | 625.84M | 5.92% |
| Oct 1, 2026 | 590.88M | -0.27% |
| Sep 30, 2026 | 592.47M | -12.77% |
| Sep 29, 2026 | 679.24M | 0.14% |
| Sep 28, 2026 | 678.29M | 8.05% |
| Sep 25, 2026 | 627.75M | -3.52% |
| Sep 24, 2026 | 650.64M | -8.37% |
| Sep 23, 2026 | 710.07M | -11.52% |
| Sep 22, 2026 | 802.57M | -5.78% |
| Sep 21, 2026 | 851.84M | 4.12% |
| Sep 18, 2026 | 818.14M | -0.45% |
| Sep 17, 2026 | 821.86M | 2.17% |
| Sep 16, 2026 | 804.40M | 18.40% |
| Sep 15, 2026 | 679.37M | 1.98% |
| Sep 14, 2026 | 666.19M | 4.22% |
| Sep 11, 2026 | 639.23M | -3.02% |
| Sep 10, 2026 | 659.15M | -2.23% |
| Sep 9, 2026 | 674.16M | -4.06% |
| Sep 8, 2026 | 702.66M | 4.18% |
| Sep 4, 2026 | 674.47M | 9.94% |
| Sep 3, 2026 | 613.49M | 3.30% |
| Sep 2, 2026 | 593.87M | 2.05% |
| Sep 1, 2026 | 581.92M | 3.77% |
| Aug 31, 2026 | 560.78M | -6.44% |
| Aug 28, 2026 | 599.39M | -1.21% |
| Aug 27, 2026 | 606.74M | 7.26% |
| Aug 26, 2026 | 565.68M | 0.22% |
| Aug 25, 2026 | 564.46M | 14.91% |
| Aug 24, 2026 | 491.22M | -2.14% |
| Aug 21, 2026 | 501.94M | 3.67% |
| Aug 20, 2026 | 484.17M | -2.29% |
| Aug 19, 2026 | 495.51M | 0.43% |
| Aug 18, 2026 | 493.36M | -1.71% |
| Aug 17, 2026 | 501.94M | 1.24% |
| Aug 14, 2026 | 495.81M | -1.04% |
| Aug 13, 2026 | 501.02M | 0.68% |
| Aug 12, 2026 | 497.65M | -1.69% |
| Aug 11, 2026 | 506.23M | 3.31% |
| Aug 10, 2026 | 489.99M | 5.31% |
| Aug 7, 2026 | 465.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zura Bio | 385.78M |
| Tectonic Therapeutic | 382.19M |
| C4 Therapeutics | 377.69M |
| Fennec Pharmaceuticals | 376.97M |
| Avalo Therapeutics | 374.07M |
| Autolus Therapeutics | 371.30M |
| Lyell Immunopharma | 371.25M |
| MapLight Therapeutics | 369.02M |